New horizons for congenital myasthenic syndromes

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


During the past five years an increasing number of patients have been diagnosed with congenital myasthenic syndromes (CMS) and a number of novel syndromes have been recognized and investigated. This presentation focuses on the CMS caused by defects in choline acetyltransferase, novel fast-channel syndromes that hinder isomerization of the acetylcholine receptor from the closed to the open state, the consequences of deleterious mutations in the intermediate filament linker plectin, altered neuromuscular transmission in a centronuclear myopathy, and two recently identified CMS caused by congenital defects in glycosylation.

Original languageEnglish (US)
Pages (from-to)54-62
Number of pages9
JournalAnnals of the New York Academy of Sciences
Issue number1
StatePublished - Dec 2012


  • Acetylcholine receptor
  • Centronuclear myopathy
  • Choline acetyltransferase
  • Congenital myasthenic syndromes
  • DPAGT1
  • Fast-channel syndromes
  • GFPT1
  • Plectin

ASJC Scopus subject areas

  • General Neuroscience
  • General Biochemistry, Genetics and Molecular Biology
  • History and Philosophy of Science


Dive into the research topics of 'New horizons for congenital myasthenic syndromes'. Together they form a unique fingerprint.

Cite this